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SUMMARY – The aim of this study was to evaluate the quantitative sonoelastographic values 
recorded on shear-wave sonoelastography (SWE) of high-risk breast lesions and ductal carcinoma in 
situ (DCIS). We retrospectively analyzed histopathologic and SWE data (quantitative maximum, 
minimum and mean stiffness, lesion-to-fat ratio (E-ratio), lesion size) of 228 women referred to our 
Department for core needle breast biopsy during a four-year period. Among 230 lesions, histopatho-
logic findings showed 34 high-risk breast lesions and 29 DCIS, which were compared with 167 ductal 
invasive carcinomas. High-risk lesions had lower values of all sonoelastographic features than ductal 
in situ and invasive carcinoma, however, only E-ratio showed a statistically significant difference in 
comparison to DCIS (3.7 vs. 6, p<0.001). All sonoelastographic features showed significant difference 
between in situ and invasive carcinoma. There was a significant correlation between lesion size and 
stiffness (r=0.36; p<0.001). Stiffness measured by SWE is an effective predictor of the histopatho-
logic severity of sonographically detectable breast lesions. Elasticity values of high-risk lesions are 
significantly lower than those of malignant lesions. Furthermore, we showed that along with the so-
nographic appearance, which in most cases shows typical microcalcifications, DCIS had significantly 
different elasticity parameters than invasive carcinoma.
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Introduction
Breast cancer is the most common cancer and the 
leading cause of cancer related death in women world-
wide, and in 2013, the incidence of breast cancer in 
Croatia was 26%, with 2557 newly diagnosed cases 
and 994 reported deaths related to breast cancer1.
Conventional gray-scale ultrasonography (US) has 
high diagnostic sensitivity, ranging from 83% to 98%, 
but lower specificity ranging from 34% to 70%2,3. There 
are difficulties in distinguishing benign and malignant 
lesions, as their US features can overlap, examination 
can be difficult in large breasts, small lesions are easily 
missed, and examiner’s experience plays a significant 
role. Sonoelastography is a relatively novel method 
that appears to be a useful tool in benign/malignant 
differentiation of solid breast masses identified on 
conventional US4-7. The latest meta-analysis of 33 
studies showed a high diagnostic accuracy of shear-
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wave sonoelastography (SWE), with a sensitivity of 
0.886 and specificity of 0.866 in benign/malignant 
differentiation8. Furthermore, when combined with 
conventional B-mode US, the sensitivity and specific-
ity of 0.971 and 0.801 have been reported8. Sonoelas-
tography could aid in reducing unnecessary breast bi-
opsies7, which remain the gold standard in diagnosing 
suspicious breast lesions.
Most of the lesions that occur in the breast are be-
nign. With the use of various imaging methods and 
fine needle aspiration (FNA), the diagnosis of benign 
breast disease can be accomplished without surgery in 
the vast majority of patients9,10. Fibrocystic changes 
represent the most frequent benign disorder of the 
breast, and can be classified as nonproliferative lesions, 
proliferative lesions without atypia, and proliferative 
lesions with atypia9,11. Nonproliferative lesions encom-
pass 70% of this group of lesions, and carry no risk of 
breast cancer development. Proliferative lesions with-
out atypia include ductal hyperplasia of the usual type, 
sclerosing adenosis, radial scar, and intraductal papil-
loma. Proliferative lesions with atypia include flat 
atypia, atypical ductal hyperplasia (ADH) and lobular 
neoplasia (atypical lobular hyperplasia (ALH), lobular 
carcinoma in situ)12.
Compared with the general population, women 
with proliferative lesions without and with atypia have 
a greater risk of subsequent breast cancer, ranging from 
1.3-1.9 and 3.9-13, respectively, and are considered as 
‘high-risk’ lesions9,11-13. Hartmann et al.13 found a sig-
nificant interaction between patient age at the diagno-
sis of benign breast disease and histologic appearance. 
The risk of breast cancer was 6.99 times the expected 
risk if atypia was diagnosed before the age of 45, but 
3.37 times the expected risk if it was diagnosed after 
the age of 55. Page and Dupont14 found 4-5 times in-
creased risk of breast cancer in women with ADH or 
ALH compared to the general population. However, 
this risk is nearly doubled if the patient has a first-de-
gree relative with breast cancer. The risk associated 
with benign breast disease is becoming even more im-
portant since the increasing use of both mammogra-
phy and US has increased the frequency of breast bi-
opsies, with the majority of benign findings. The man-
agement of these patients includes imaging follow-up 
or surgical excision, which is advocated in cases of 
proliferative lesions with atypia and other high-risk le-
sions.
The widespread use of mammography in breast 
screening has also led to increased detection of ductal 
carcinoma in situ (DCIS), due to the frequent presence 
of microcalcifications within the lesions. DCIS now 
accounts for 15%-20% of detected cancers15. It is de-
fined as an intraductal proliferation of malignant epi-
thelial cells with no evidence for invasion of the base-
ment membrane9. Lesions are primarily classified 
based on their cytonuclear differentiation as poorly, 
intermediately and well differentiated; in addition, 
based on architectural differentiation, they can be cat-
egorized as solid and non-solid15. DCIS is a nonoblig-
atory precursor of invasive breast cancer, and it is esti-
mated that up to 40% will progress if untreated16. Most 
cases of DCIS are diagnosed on mammography, and 
US is not traditionally used as a primary diagnostic 
modality for DCIS because it is less sensitive for iden-
tifying microcalciﬁcations.
Percutaneous ultrasound guided core needle biopsy 
(CNB) is an accurate, safe, quick and effective tool for 
histologic diagnosis of breast lesions17. It has a high 
sensitivity of 96%, and a false-negative rate of 2.4% for 
malignant lesions18. It can reduce the cost of diagnosis 
of indeterminate or suspicious lesions, causes minimal 
or no scarring, and is generally more acceptable for pa-
tients than surgical excision. A limited sample ob-
tained from CNB (mostly 3-5 specimens per biopsy) 
may result in ‘histologic underestimation’, as 20%-56% 
of ADH lesions diagnosed at CNB contain foci of 
cancer at subsequent surgery excision, and among le-
sions previously diagnosed as DCIS, 16%-35% con-
tain invasive carcinoma17.
There are many published studies about SWE dif-
ferences among specific types of invasive ductal carci-
noma and between ductal and lobular carcinoma4-8,19-22, 
but very few articles describe the quantitative sono-
elastographic features of high-risk lesions and 
DCIS21,24,26. The purpose of this study was to examine 
the SWE features of high-risk breast lesions and 
DCIS in a relatively small group of patients.
Patients and Methods
The institutional Review Board approval was ob-
tained for this retrospective study. Analysis was per-
formed of our breast biopsy database for patients re-
ferred for core biopsy during a four-year period, in 
which SWE examination had been performed along 
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with US during diagnostic workup. B-mode features, 
SWE data, pathologic and surgical records of these 
patients were reviewed. Among the lesions that under-
went core biopsy, any atypical, suspicious or malignant 
result prompted surgical excision, as decided on multi-
disciplinary team meetings. Patients with high-risk le-
sions and DCIS, as confirmed with histopathology 
findings, were included in the study. DCIS group con-
sisted of 29 patients with pure in situ lesions, without 
microinvasive component on histopathology. If the 
microinvasive component was noted, lesions were con-
sidered invasive cancers. Regarding the high-risk 
group, 34 patients had this type of lesions. For com-
parison, we included data on 167 patients diagnosed 
with invasive ductal carcinoma found during the same 
period. Relevant clinical information was obtained 
from patient clinical and breast imaging reports on the 
lesions that met the inclusion criteria. Information in-
cluded patient age, personal history of breast cancer, 
information on previous breast surgery, lesion size, 
Breast Imaging-Reporting and Data System (BI-
RADS) description and assessment.
All patients underwent SWE examination on the 
same Aixplorer (Supersonic Imagine, Aix en Provence, 
France) US scanner equipped with linear high-fre-
quency transducer (4-15 MHz). Gray scale and sono-
elastographic examinations were performed during the 
regular diagnostic process, by a single radiologist with 
25-year experience in breast imaging and breast US 
(the last author). The images obtained were stored at 
the scanner hard drive. The protocol for SWE data ac-
quisition was standardized, with optimal setting of fo-
cus of the lesion, without manual compression on the 
probe. Lesion stiffness was measured by using the 
built-in quantification region of interest (ROI; Q-
box), with ROI set at 2x2 mm in all measurements. 
ROI was always placed over the stiffest part of the le-
sion or its edge, with the most intense red color, usu-
ally at the lesion margin, which correlates with lesion 
stiffness in kilopascals (kPa). Also, a second ROI of the 
same size was employed in calculating the lesion-to-
fat ratio (E-ratio), used to compare the lesion stiffness 
with that of breast fatty tissue. All measurements were 
made in the same preset (breast preset on the scanner, 
penetration mode), with the highest stiffness set at 
≥180 kPa. Elastography values displayed in the data 
box next to the image were obtained and recorded as 
mean (Emean), maximum (Emax), minimum (Emin) 
stiffness, and the above mentioned E-ratio. The high-
est measured values were recorded for a single patient. 
After SWE, 14G core biopsy was performed, regard-
less of the results of the SWE studies. The criteria for 
indicating a biopsy were based on the mammography, 
gray-scale US and/or magnetic resonance imaging 
(MRI) findings, or previous suspicious FNA findings. 
Biopsies were performed using the same US scanner 
for guidance, by the same radiologist.
Clinical parameters and elastographic features 
were expressed as mean ± standard deviation or medi-
an with interquartile range (IQR), depending on data 
distribution. Differences between the groups were 
tested using Kruskal-Wallis test followed by Mann-
Whitney or ANOVA test followed by Student-New-
man-Keuls for post hoc comparisons, as indicated for 
particular variable.
The receiver operating characteristic (ROC) curve 
analysis was performed. The area under curve (AUC) 
with its 95% confidence intervals (95% CI) was used 
to determine the efficacy of elasticity parameters to 
discriminate between these groups. Diagnostic efficacy 
for elasticity parameters was assessed through sen-
sitivity and specificity. Statistical analysis was per-
formed using the MedCalc software package (Mar-
iakerke, Belgium). For all calculations, the a level was 
set at 0.05.
Results
Thirty-four patients comprised the high-risk lesion 
group, median age 56 (range 37-76) years. Patients 
with DCIS (n=29) were slightly older, median age 59 
(range 28-86), as were patients with invasive carcino-
ma (n=167, median age 59, range 31-90), however, the 
groups did not differ significantly according to age 
(Table 1).
The median size of all evaluated lesions was 15 mm 
(mean 17.2 mm; SD 9.6 mm; range 4-54 mm), with 
no significant difference between the lesion groups 
(Table 1). There was a significant correlation between 
lesion size and stiffness (r=0.36; p<0.001) (Fig. 1). The 
subgroup analysis of the high-risk lesion group showed 
ductal proliferative changes with atypia (ADH) to be 
the most frequent finding (n=20), with the mean size 
of 14.6 mm. Lobular neoplasia was observed in five 
patients (2 lobular carcinomas in situ and 3 atypical 
lobular hyperplasia lesions), and it comprised the larg-
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Table 1. General and sonoelastographic characteristics of high-risk lesions, ductal carcinoma  
in situ and ductal invasive carcinoma on shear-wave elastography
HRL DCIS IDC
Number of tumors 34 29 167
Agea (years) 56 (37-76) 59 (28-86) 59 (31-90)
Sizeb (mm) 15.1±7.1 18.6±11.1 17.2±9.7
Emaxb (kPa) 124.8±61.3† 143.7±49.9† 192.1±59.5*#
Emeanb (kPa) 108.1±52.5† 125.8±42.9† 164.8±49*#
Eminb (kPa) 86.4±45.1† 97.2±35.7† 127.4±42.2*#
E-ratioa 3.7 (2.6-5)#† 6 (4.6-7.8)*† 7 (5.5-10)*#
aValue is presented as median with range; Kruskal-Wallis test followed by Mann-Whitney-U test was used; 
bvalue is presented as mean ± standard deviation; for statistical evaluation, ANOVA followed by Student-
Newman-Keuls test post-hoc comparisons tests were used; *p<0.05 in comparison with HRL; #p<0.05 in 
comparison with DCIS; †p<0.05 in comparison with IDC; HRL = high risk lesions; DCIS = ductal carci-
noma in situ; IDC = invasive ductal carcinoma; Emax = maximum stiffness; Emean = mean stiffness; Emin = 
minimum stiffness; E-ratio = lesion-to-fat ratio
Fig. 1. Correlation of maximum lesion diameter (mm) 
and maximum lesion stiffness (kPa).
HRL = high risk lesions; DCIS = ductal carcinoma in situ; IDC = 
invasive ductal carcinoma; Emax = maximum stiffness
est lesion in the group, with the mean size of 18.7 mm. 
Papillomas were found in five patients, mean size 14.7 
mm, while radial scar was observed in four patients 
with the mean size of 15 mm. The DCIS group that 
included pure in situ lesions had a mean size of 18.5 
mm, which was not a significant difference in lesion 
size compared to other groups. The mean size of in-
cluded invasive ductal carcinomas was 17.2 mm.
Quantitative values of maximal, mean and minimal 
elasticity, and E-ratio of high-risk group, DCIS group 
and invasive cancers are presented in Table 1. Sono-
elastographic features were compared between the 
high-risk and DCIS groups. They were also compared 
with features of invasive ductal cancers diagnosed in 
the same period. The high-risk group and DCIS group 
had significantly lower values of all sonoelastographic 
features as compared with patients with invasive can-
cer (p<0.001) (Table 1).
When comparing in situ and high-risk lesions, all 
sonoelastographic parameters were higher in DCIS, 
however, only E-ratio (6 vs. 3.7) showed a statistically 
significant difference (p<0.001) (Table 1, Fig. 2).
The ability of elasticity values to discriminate be-
tween the investigated groups was analyzed using 
ROC curves. In situ and invasive carcinoma could be 
distinguished by all investigated elasticity parameters, 
as follows: Emax (AUC 0.736, 95% CI 0.668-0.796, 
p<0.0001), Emean (AUC 0.722, 95% CI 0.654-0.784, 
p<0.0001), Emin (AUC 0.709, 95% CI 0.640-0.771, 
p<0.0001), and E-ratio (AUC 0.631, 95% CI 0.559-
0.699, p<0.05). High-risk lesions could be distin-
guished from in situ lesions by E-ratio (AUC 0.759, 
95% CI 0.635-0.858, p=0.0001). Discriminatory 
 ability of elasticity parameters between high-risk and 
in situ lesions and in situ vs. invasive carcinomas using 
the sensitivity and specificity at the specified cut-off 
point according to ROC curves is presented in Figures 
2 and 3.
Within the high-risk group, stiffness of lesions var-
ied among different subgroups. Radial scar lesions 
were the stiffest in the group (Emax 193.2±70.9 kPa). 
ADH had mean Emax 120±60.6 kPa, papillomas had 
Emax 111.5±45.6 kPa, while lobular neoplasia were 
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the softest lesions, with mean Emax 102.8±45.9 kPa. 
A small number of patients within each subgroup 
made the analysis of differences in elasticity features 
unreliable.
Regarding the gray-scale findings of DCIS lesions 
included in our study, 16 lesions presented as a hetero-
geneous area, mostly isoechoic to breast parenchyma, 
12 of them with hyperechoic dots representing inter-
nal microcalcifications, and 3 with duct dilatation. An-
other 13 DCIS lesions presented as hypoechoic areas, 
with internal calcifications in 5 lesions. There was no 
difference in lesion stiffness according to sonographic 
findings, however, lesions with visible microcalcifica-
tions were slightly stiffer, and only two of 16 had Emax 
values under 100 kPa.
Discussion
This pilot study conducted in a relatively small 
group of patients presented sonoelastographic features 
of high-risk lesions, a very important group of breast 
lesions that carry a significantly increased risk of breast 
Fig. 2. Discriminatory ability of maximum, mean and minimum lesion stiffness and lesion-to-fat stiffness ratio 
between high-risk breast lesions and ductal carcinoma in situ, according to receiver operating characteristic (ROC) 
curves. Diagnostic efficacy for those values was assessed using the sensitivity and specificity at the specified cut-off point. 
ROC curve analysis, p values = 0.05 were considered statistically significant.
Emax = maximum stiffness; Emean = mean stiffness; Emin = minimum stiffness; E-ratio = lesion-to-fat ratio
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cancer development. Sonoelastographic features of 
DCIS were also presented.
The study confirmed SWE to be a valuable adjunc-
tive tool for differentiation of benign and malignant 
breast lesions, as demonstrated in several studies so 
far4-7,21, and that it could also be used to differentiate 
ductal in situ from invasive breast carcinoma. A few 
previous studies have described diagnostic perfor-
mance of elasticity parameters, with various results re-
garding their discriminatory value, where some4,22,23 
have described the E-ratio as most valuable in benign/
malignant differentiation. In our study, the E-ratio 
proved to be the best, i.e. the only discriminatory so-
noelastographic feature between high-risk lesions and 
DCIS, which might have clinical importance.
Several studies have reported the correlation be-
tween lesion size and stiffness21,24,25, which was con-
firmed by our finding of a significant correlation be-
tween overall lesion size and stiffness (Fig. 1). In their 
study of more than 1500 breast lesions, Berg et al.24 
also report that high-risk lesions are stiffer than usual 
benign lesions (median Emax 71 kPa vs. 45 kPa), and 
softer than DCIS and malignant carcinomas, which is 
concordant with our results. The median Emax of 12 
Fig. 3. Discriminatory ability of maximum, mean and minimum lesion stiffness and lesion-to-fat stiffness ratio 
between ductal carcinoma in situ and ductal invasive carcinoma, according to receiver operating characteristic (ROC) 
curves. Diagnostic efficacy for those values was assessed using the sensitivity and specificity at the specified cut-off point. 
ROC curve analysis, p values = 0.05 were considered statistically significant.
Emax = maximum stiffness; Emean = mean stiffness; Emin = minimum stiffness; E-ratio = lesion-to-fat ratio
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DCIS lesions in the first large study by Berg et al.26 
was 133 kPa (IQR 72-180), whereas in the other, pre-
viously cited study24 maximum stiffness of 23 DCIS 
lesions was 126 kPa (71-180). These results are slightly 
lower than ours (143.7 kPa), which might be explained 
by the use of a prototype machine in the study by Berg 
et al., where the maximum display of 180 kPa was used. 
Presumably for the same reason, the maximum stiff-
ness of ductal invasive carcinomas was slightly higher 
in our study (192.1 kPa) compared to 180 kPa in their 
study.
The mean stiffness of DCIS (7 lesions) is reported 
to be 117.8±54.72 kPa21, which is quite similar to our 
value of 125.8±42.9 kPa. Another study showed that 
DCIS lesions were softer than invasive malignant le-
sions27, however, without precise quantitative values. 
DCIS lesions tend to show benign sonoelastographic 
characteristics, i.e. false-negative sonoelastographic re-
sults, and with the cut-off value of 50 kPa set for 
Emean 4/9 lesions could be considered soft. With a 
threshold maximum stiffness of 80 kPa26, 6/29 lesions 
(20.7%) in our DCIS group would be misclassified. 
With the same cut-off value, the false-negative rate for 
malignancy in the group of invasive carcinoma would 
be 5.4%, which is in line with previous studies26-28.
In a recent study, Lee et al.29 have presented inter-
esting and detailed US findings of 126 DCIS lesions, 
with positive ﬁndings in 86.5% of lesions, including 
19 mammography negative cases. Non-mass lesions 
with microcalciﬁcations on mammography presented 
mainly as heterogeneous hyper- or isoechoic parenchy-
ma with visible hyperechoic dots, without posterior 
acoustic features, while mass lesions had oval shape, 
parallel orientation and were mildly hypoechoic. DCIS 
lesions without microcalciﬁcations presented as a round 
or oval mass, with microlobulated margin and parallel 
orientation, also heterogeneous and hypoechoic. Our 
gray-scale US findings are consistent with the above 
mentioned study, showing that DCIS mainly presents 
as a heterogeneous area, primarily hyper- or isoechoic, 
with detectable microcalcifications, seen as hyperechoic 
dots within the lesion in the majority of cases.
Fig. 4. Ductal in situ carcinoma – sonoelastographic and gray-scale ultrasound image.
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The most frequent lesion in our high-risk group 
was ADH. Compared to a previous study24, maximum 
stiffness values were somewhat higher in our study 
(120 kPa vs. 83 kPa), but again lesions in our group 
were larger and higher in numbers (20 vs. 4 ADH le-
sions). Papillary breast lesions are uncommon, and ma-
lignant forms comprise less than 2% of all breast can-
cers9,30. Previous studies suggest that size is a signifi-
cant indicator of malignancy, and papillary lesions 
larger than 1 cm are more likely to be malignant31,32. 
Papillomas in our study group had the mean size of 
14.7 mm and were found in older patients (age 59). 
Maximum stiffness was rather high, with mean Emax 
111.5±45.6 kPa. The previously reported maximum 
stiffness of papillomas was 100 kPa, 87.7 kPa and 60.6 
kPa24,31,32. Another lesion included in the high-risk 
group is radial scar, which is considered as a benign 
proliferative lesion, but can be associated with atypia 
and/or malignancy on histology, and was found to in-
crease the relative risk of breast cancer 1.33 to 2 
times33,34. They are characterized as a central fibroelas-
tic core with radially arranged ducts and lobules9. Ra-
dial scars are especially interesting as they are also very 
similar to invasive cancer on mammography. We had 
four radial scars in our study group, with the mean size 
of 15 mm and very high stiffness (mean Emax 
193.2±70.9 kPa). Berg et al.24 report somewhat lower 
values (Emax 105 kPa), but two radial scar lesions in-
cluded in their study were much smaller (median di-
ameter 5 mm), so this could explain the discrepancy. 
Maximum stiffness values of lobular carcinoma in situ 
(LCIS) have been reported to be 88.65 kPa and 41.1 
kPa35,36. Presently, the Emax values are higher than the 
above-mentioned elasticity values (102.8 kPa). As 
LCIS and ALH are mostly incidental findings during 
diagnostic workup of calcifications or associated mass 
lesions, we can hypothesize that these differences 
could be the result of concomitant pathology and cal-
cification content, along with the size of the lesions 
included. Apparently, considerable heterogeneity of 
SWE features was observed among high-risk lesions.
There were several limitations to our study. We en-
rolled a relatively small study population in the high-
risk and DCIS groups, and in high-risk lesion sub-
group analysis. Also, due to the retrospective design of 
the study, there might have been selection bias because 
some of included patients were referred to our breast 
center from other institution for secondary manage-
ment and core biopsy, so there might have been a 
higher incidence of complex lesions, especially in the 
high-risk group. Larger prospective studies are re-
quired to further investigate high-risk breast lesions, in 
larger cohorts of patients. Interobserver variability was 
not assessed, since a single examiner performed the 
measurements, but the method has been shown previ-
ously as highly reproducible if a uniform examination 
technique is utilized6,37.
Our study demonstrated that elasticity values of 
high-risk lesions were lower than those of both in situ 
and invasive cancers, and a significant difference was 
observed between in situ and invasive lesions. Conse-
quently, sonoelastographic features can help in the dis-
tinction of lesions that carry a higher risk of malig-
nancy and malignant lesions. Since high-risk lesions 
and DCIS detection has increased owing to wide-
spread screening programs, increasing number of US 
examinations and image-guided tissue sampling, they 
are coming into the focus of interest for both diagnosis 
and treatment.
We believe that sonoelastography has a potential to 
help in the early diagnosis of these lesions and further 
studies are needed to demonstrate its place in the diag-
nostic algorithm.
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Sažetak
SONOELASTOGRAFSKE KARAKTERISTIKE LEZIJA DOJKE VISOKOG RIZIKA  
I DUKTALNOG KARCINOMA IN SITU – PROBNO ISTRAŽIVANJE
M. Crnogorac, G. Ivanac, Č. Tomasović-Lončarić, R. Žic, T. Kelava i B. Brkljačić
Cilj ove studije bio je izmjeriti kvantitativne vrijednosti tvrdoće lezija dojke visokog rizika i duktalnog karcinoma in situ 
(DKIS) pomoću shear-wave sonoelastografije. Retrospektivno smo analizirali patohistološke, ultrazvučne i elastografske po-
datke (maksimalna, srednja i minimalna tvrdoća, omjer tvrdoće lezije i masnog tkiva (E-omjer), veličina lezije) 228 bolesnica 
upućenih tijekom četvorogodišnjeg razdoblja na naš odjel radi biopsije dojke širokom iglom. Patohistološki su među 230 
lezija dojke dijagnosticirane 34 lezije dojke visokog rizika, 29 duktalnih karcinoma in situ te 167 invazivnih duktalnih karci-
noma dojke. Lezije visokog rizika pokazale su niže vrijednosti svih elastografskih parametara u usporedbi s duktalnim in situ 
i invazivnim karcinomima, no u usporedbi s DKIS jedino je E-omjer pokazao značajnu razliku tvrdoće (3,7 prema 6; 
p<0,001). Sve su se sonoelastografske vrijednosti značajno razlikovale pri usporedbi duktalnih in situ i invazivnih karcinoma. 
Nađena je značajna povezanost veličine i tvrdoće lezije (r=0,36; p<0,001). Tvrdoća mjerena shear-wave sonoelastografijom 
dobro korelira s patohistološkim nalazom lezija dojke koje se mogu otkriti ultrazvukom. Vrijednosti tvrdoće lezija visokog 
rizika su značajno niže od onih kod malignih lezija. Također smo pokazali da DKIS, uz ultrazvučni nalaz tipičnih mikrokal-
cifikata u najvećem broju slučajeva, ima i značajno manje vrijednosti tvrdoće od invazivnih karcinoma.
Ključne riječi: Dojka, tumori – dijagnostika; Dojka, tumori – klasifikacija; Elastični modul; Ultrazvučno snimanje dojke; Ela-
stičnost, slikovne tehnike; Osjetljivost i specifičnost; Karcinom, duktalni; Shear-wave elastografija
